Nilandron
- Product NDC
- 59212-111
- 11-digit product format
- 592120111
- Labeler code
- 59212
- Product ID
- 59212-111_e834bedb-32de-4f3a-b9f3-cb5f4804d046
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nilutamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Concordia Pharmaceuticals Inc.
- Application
- NDA020169
- Marketing category
- NDA
- Marketing start
- 2013-07-15
- Marketing end
- 0000-00-00
- Substance
- NILUTAMIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59212-111 | NILANDRON (NILUTAMIDE) TABLET [ADVANZ PHARMA (US) CORP.] | 8 | Legacy NDC | 20241210_5ccf0e9a-8935-4c8c-b883-b4967281eb4a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59212-111-14 | 59212011114 | 3 BLISTER PACK in 1 CARTON (59212-111-14) > 10 TABLET in 1 BLISTER PACK | 3 blister pack | 2013-07-15 | 0000-00-00 | No | No | Current |